InsiderClue
← All stocks

Arcturus Therapeutics Holdings Inc.

ARCT Net selling
CIK 0001768224 #3570 in the set updated 18 Sep 2026
Bought (120 mo)
$787.85K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$138.48M
$4.92M on a plan · $440.24K straight out of an exercise
Sold at will
$133.12M
21 of 39 sales
Net
−$137.69M
−$132.33M against sales at will

By person

11 insiders · 54 transactions
32.6×

Joseph E. Payne holds 32.6 times base salary in stock. $24.51M of shares against $750.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph E. Payne last reported holding, valued at $16.56, the price Common Stock was last bought or sold at on the open market here, on 15 Aug 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ultragenyx Pharmaceutical Inc. entity
Director
—
$124.28M (4)
−$124.28M
1,400,000
4.93%
$23.18M
−41.7%
Chivukula Pad
Chief Scientific Officer & COO
—
$12.16M (32)
−$12.16M
435,334
1.53%
$7.21M
−40.6%
SASSINE ANDY
Chief Financial Officer
$433.16K (5)
$1.60M (1)
−$1.17M
221,764
0.7802%
$3.67M
−7.6%
Kummerfeld Keith C
See Remarks
$20.35K (2)
$440.24K (2) scheduled
−$419.89K
950
0.0033%
$15.73K
—
Payne Joseph E
President and CEO
$170.34K (3)
—
+$170.34K
1,480,097
5.21%
$24.51M
+0.7%
FARRELL PETER C
Director
$99.67K (2)
—
+$99.67K
98,696
0.3472%
$1.63M
+14.2%
Marquet Magda
Director
$64.33K (2)
—
+$64.33K
50,793
0.1787%
$841.03K
+17.7%
BARLOW JAMES F
Director
—
—
—
13,131
0.0462%
$217.42K
+31.3%
Markels John
Director
—
—
—
3,131
0.0110%
$51.84K
—
Marantz Jing L.
Director
—
—
—
3,131
0.0110%
$51.84K
—
HOLMES EDWARD W
Director
—
—
—
3,131
0.0110%
$51.84K
—

Individual transactions

54
Insider
Date
Role
Action
Shares
Price
Amount
SASSINE ANDY
15 Aug 2025
Chief Financial Officer
Buy
1,238
$16.56
$20.50K
Chivukula Pad
15 Oct 2024
Chief Scientific Officer & COO
Sold on a plan
12,000
$20.76
$249.12K
SASSINE ANDY
12 Jun 2024
Chief Financial Officer
Sell
50,000
$32.03
$1.60M
Chivukula Pad
5 Jun 2024
Chief Scientific Officer & COO
Sold on a plan
114
$45.00
$5.13K
Chivukula Pad
3 Jun 2024
Chief Scientific Officer & COO
Sold on a plan
26,000
$40.01
$1.04M
Chivukula Pad
25 Mar 2024
Chief Scientific Officer & COO
Sold on a plan
17,435
$35.02
$610.57K
Chivukula Pad
19 Mar 2024
Chief Scientific Officer & COO
Sold on a plan
8,565
$35.01
$299.84K
Chivukula Pad
1 Nov 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$18.72
$93.60K
Chivukula Pad
2 Oct 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$25.61
$128.06K
Chivukula Pad
1 Sep 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$31.45
$157.26K
Chivukula Pad
1 Aug 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$34.91
$174.55K
Kummerfeld Keith C
14 Jul 2023
See Remarks
Sold after exercise
6,968
$35.00
$243.88K
Chivukula Pad
14 Jul 2023
Chief Scientific Officer & COO
Sold on a plan
25,000
$35.01
$875.25K
Chivukula Pad
3 Jul 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$28.75
$143.75K
Chivukula Pad
1 Jun 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$27.16
$135.80K
Chivukula Pad
11 May 2023
Chief Scientific Officer & COO
Sold on a plan
7,925
$30.24
$239.65K
Chivukula Pad
10 May 2023
Chief Scientific Officer & COO
Sold on a plan
17,075
$30.00
$512.25K
Chivukula Pad
1 May 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$25.93
$129.65K
Kummerfeld Keith C
18 Apr 2023
See Remarks
Sold after exercise
6,968
$28.18
$196.36K
Chivukula Pad
3 Apr 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$25.38
$126.90K
Chivukula Pad
6 Mar 2023
Chief Scientific Officer & COO
Sell
5,000
$16.07
$80.35K
Marquet Magda
15 Dec 2022
Director
Buy indirect
2,222
$18.00
$40.00K
Payne Joseph E
23 Nov 2022
President and CEO
Buy
5,000
$16.51
$82.55K
Chivukula Pad
4 Jan 2022
Chief Scientific Officer & COO
Sell
8,100
$40.00
$324.00K
Chivukula Pad
16 Dec 2021
Chief Scientific Officer & COO
Sell
3,633
$40.00
$145.33K
Chivukula Pad
8 Dec 2021
Chief Scientific Officer & COO
Sell
6,367
$40.00
$254.68K
Chivukula Pad
1 Nov 2021
Chief Scientific Officer & COO
Sell
10,000
$44.41
$444.10K
Chivukula Pad
1 Oct 2021
Chief Scientific Officer & COO
Sell
10,000
$44.36
$443.60K
Chivukula Pad
1 Sep 2021
Chief Scientific Officer & COO
Sell
10,000
$55.86
$558.60K
Ultragenyx Pharmaceutical Inc.
11 Aug 2021
Director
Sell
75,000
$45.83
$3.44M
Ultragenyx Pharmaceutical Inc.
10 Aug 2021
Director
Sell
725,000
$55.44
$40.19M
Chivukula Pad
3 Aug 2021
Chief Scientific Officer & COO
Sell
10,000
$40.07
$400.70K
Chivukula Pad
1 Apr 2021
Chief Scientific Officer & COO
Sell
10,000
$42.95
$429.50K
Chivukula Pad
1 Mar 2021
Chief Scientific Officer & COO
Sell
10,000
$54.23
$542.30K
Chivukula Pad
1 Feb 2021
Chief Scientific Officer & COO
Sell
10,000
$75.31
$753.10K
Chivukula Pad
4 Jan 2021
Chief Scientific Officer & COO
Sell
10,000
$46.40
$464.00K
Ultragenyx Pharmaceutical Inc.
9 Dec 2020
Director
Sell
357,745
$94.97
$33.98M
Ultragenyx Pharmaceutical Inc.
8 Dec 2020
Director
Sell
442,255
$105.54
$46.68M
Chivukula Pad
1 Dec 2020
Chief Scientific Officer & COO
Sell
10,000
$96.19
$961.90K
Chivukula Pad
2 Nov 2020
Chief Scientific Officer & COO
Sell
10,000
$55.28
$552.80K
Chivukula Pad
1 Oct 2020
Chief Scientific Officer & COO
Sell
10,000
$42.83
$428.30K
Chivukula Pad
3 Sep 2020
Chief Scientific Officer & COO
Sell
10,000
$45.16
$451.60K
Kummerfeld Keith C
12 Jun 2020
See Remarks
Buy
450
$33.33
$15.00K
SASSINE ANDY
10 Jun 2020
Chief Financial Officer
Buy
5,000
$29.74
$148.70K
Payne Joseph E
10 Jun 2020
President and CEO
Buy
1,000
$31.69
$31.69K
Ultragenyx Pharmaceutical Inc.
20 May 2020
Director
Exercised, kept
600,000
$16.00
$9.60M
SASSINE ANDY
5 Dec 2019
Chief Financial Officer
Buy
5,649
$9.73
$54.96K
SASSINE ANDY
3 Dec 2019
Chief Financial Officer
Buy
10,000
$10.00
$100.00K
Marquet Magda
13 Sep 2019
Director
Buy indirect
2,300
$10.58
$24.33K
Kummerfeld Keith C
12 Sep 2019
See Remarks
Buy
500
$10.69
$5.35K
Payne Joseph E
29 Aug 2019
President and CEO
Buy
5,000
$11.22
$56.10K
SASSINE ANDY
23 Aug 2019
Chief Financial Officer
Buy
10,000
$10.90
$109.00K
FARRELL PETER C
20 Aug 2019
Director
Buy indirect
4,432
$10.85
$48.09K
FARRELL PETER C
19 Aug 2019
Director
Buy indirect
4,681
$11.02
$51.58K

What was left out

Form 4 filings counted 137
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 2
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 635,013
Sales filed before the plan box existed 20
History held since 21 Aug 2019